drugset

drugset / Trial / NCT03332186

A Study of Experimental Medication BMS-986231 in Patients With Different Levels of Kidney Function

NCT03332186 ↗

Phase 1 Completed 48 enrolled Bristol-Myers Squibb

Non-randomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to investigate experimental medication BMS-986231 in patients with different levels of kidney function.

Timeline

Start: 2018-03-15
Primary completion: 2018-10-22
Completion: 2018-10-22

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	cimlanod	Other / unclassified	—	Intravenous

Indications